UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.07B |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.25B |
| 3 |
Costco
COST
|
+$252M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Advanced Micro Devices
AMD
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$274M |
| 2 |
UnitedHealth
UNH
|
+$207M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$204M |
| 4 |
Home Depot
HD
|
+$203M |
| 5 |
Qualcomm
QCOM
|
+$200M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.71% |
| 2 | Healthcare | 12.08% |
| 3 | Financials | 11.18% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Communication Services | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Glaukos
GKOS
$10.6B
| $6.3M | ﹤0.01% |
66,864
+7,162
| +12% | +$640K |
|
|
SUM
1127
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $6.3M | ﹤0.01% |
141,318
-3,695
| -3% | -$146K |
|
1128
Noble Corp
NE
$6.51B
| $6.28M | ﹤0.01% |
129,556
+2,800
| +2% | +$126K |
|
|
DCPH
1129
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $6.27M | ﹤0.01% |
398,540
-1,504
| -0.4% | -$23.1K |
|
|
CWAN
1130
DELISTED
Clearwater Analytics
CWAN
| $6.26M | ﹤0.01% |
354,112
-327,552
| -48% | -$6.09M |
|
|
PR
1131
Permian Resources
PR
$16.9B
| $6.2M | ﹤0.01% |
351,200
+27,821
| +9% | +$408K |
|
1132
IPG Photonics
IPGP
$3.84B
| $6.15M | ﹤0.01% |
67,800
+2
| +0% | +$188 |
|
|
AIV
1133
Aimco
AIV
$383M
| $6.13M | ﹤0.01% |
748,453
+45,278
| +6% | +$346K |
|
1134
Immunocore
IMCR
$1.73B
| $6.12M | ﹤0.01% |
94,117
-11,568
| -11% | -$794K |
|
1135
Arcturus Therapeutics
ARCT
$211M
| $6.09M | ﹤0.01% |
180,398
+154,444
| +595% | +$5.47M |
|
1136
Ultragenyx Pharmaceutical
RARE
$2.55B
| $6.08M | ﹤0.01% |
130,260
+12,054
| +10% | +$569K |
|
|
CADE
1137
DELISTED
Cadence Bank
CADE
| $6.08M | ﹤0.01% |
209,584
-4,345
| -2% | -$121K |
|
1138
Merit Medical Systems
MMSI
$5.32B
| $6.07M | ﹤0.01% |
80,150
+8,156
| +11% | +$630K |
|
1139
Southwest Gas
SWX
$6.67B
| $6.07M | ﹤0.01% |
79,726
-10,930
| -12% | -$708K |
|
1140
EXL Service
EXLS
$5.29B
| $6.04M | ﹤0.01% |
189,807
+5,383
| +3% | +$167K |
|
1141
American States Water
AWR
$3.46B
| $6.03M | ﹤0.01% |
83,426
-285
| -0.3% | -$21.2K |
|
1142
Carter's
CRI
$1.47B
| $6.01M | ﹤0.01% |
70,918
+3,433
| +5% | +$272K |
|
1143
Murphy Oil
MUR
$4.78B
| $6M | ﹤0.01% |
131,297
-6,843
| -5% | -$276K |
|
1144
Maximus
MMS
$3.1B
| $6M | ﹤0.01% |
71,493
-106
| -0.1% | -$8.72K |
|
1145
First Interstate BancSystem
FIBK
$3.58B
| $6M | ﹤0.01% |
220,390
+90,537
| +70% | +$2.47M |
|
1146
Box
BOX
$4.6B
| $5.97M | ﹤0.01% |
210,830
+18,289
| +9% | +$491K |
|
1147
Xencor
XNCR
$1.55B
| $5.97M | ﹤0.01% |
269,693
+351
| +0.1% | +$7.58K |
|
1148
Aaon
AAON
$7.77B
| $5.95M | ﹤0.01% |
67,580
+499
| +0.7% | +$39.1K |
|
1149
FTAI Aviation
FTAI
$22.2B
| $5.95M | ﹤0.01% |
88,430
+8,122
| +10% | +$446K |
|
1150
Group 1 Automotive
GPI
$3.18B
| $5.92M | ﹤0.01% |
20,258
+1,958
| +11% | +$535K |
|
Similar funds
UBS AM's Q1 2024 Portfolio in Review
As of Q1 2024, UBS AM held 2,593 positions worth $281B, up 11% from $254B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 4.9%. UBS AM opened 53 new positions and exited 73, leaving the 2,593-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2024 buy was iShares Core MSCI EAFE ETF: 57,224,039 shares worth $4.25B.
- UBS AM added most to Costco in Q1 2024, an estimated $252M increase.
- UBS AM's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $274M.
- UBS AM fully exited Splunk Inc in Q1 2024, selling an estimated $204M.
- UBS AM's ten largest holdings make up 27% of its $281B portfolio in Q1 2024.
- UBS AM opened 53 new positions and closed 73 in Q1 2024.
- UBS AM's portfolio value rose 11% quarter-over-quarter to $281B.
Based on UBS AM's 13F filing for Q1 2024, filed 15 May 2024.